External stimuli like loud noises and strong odors cause migraine sensory overload, affecting your sense of touch, smell, ...

“Ubrogepant 100 mg, when administered in the premonitory (prodromal) phase of migraine, before a headache has commenced, may treat symptoms such as photophobia, phonophobia, and cognitive dysfunction, ...

A new study published in the Journal of American Medical Association showed that rizatriptan did not effectively relieve ...

Results from a phase 3 clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent ...

Migraines are far more than just severe headaches. For millions, migraines often come with a myriad of disruptive symptoms, ...

Gensco Laboratories LLC d/b/a Gensco Pharma, (Gensco or the Company) a leader in specialty pharmaceuticals, proudly announces the acquisition of the global rights and intellectual property for the ...

aggravation by routine physical activity and association with nausea and/or photophobia and phonophobia. Previously it was called common migraine 1.2 MA Recurrent disorder manifesting in attacks ...

Administration of ubrogepant during the prodromal phase of migraine may alleviate symptoms such as photophobia, phonophobia, and cognitive dysfunction. HealthDay News — Ubrogepant during the ...

Absence of phonophobia occurred in 50.7 and 35.8 percent of events at four hours postdose (odds ratio, 1.97); and at 24 hours post-dose, absence of dizziness occurred in 88.5 and 82.3 percent of ...